ViaCyte Company
ViaCyte is developing islet cell replacement therapy to cure diabetes.
Investors
.png)
Technology:
Regenerative Medicine
Industry:
BioEngineering
Headquarters:
California, United States
Founded Date:
1999
Employees Number:
51-100
Investors Number:
17
Total Funding:
$235.5M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership